Quest Diagnostics: Barclays raises target price to $260 from $250
DGX•Barclays raised its target price for Quest Diagnostics to $260 from $250.
Related News
Moody's Corporation: Morgan Stanley cuts target price to $470 from $512
MCO•
Lifezone Metals cuts BHP consideration cap by US$8 million after IFC PS5 resettlement review
LZM•
Marvell Technology raises target price to $300 from $268
MRVL•
Citigroup cuts UPS target price to $122 from $132
UPS•
Gogoro sells 24,936,057 unregistered shares in $61.8 million private placement
GGR•